Allostery enables selective and context-dependent regulation of biological function. Although classically associated with proteins, RNA also samples dynamic conformational ensembles in which ligand binding can be coupled to a spatially or functionally distinct output. Allosteric RNA aptamers harness this property to convert molecular inputs into fluorescence, catalysis, RNA processing, translational control, macromolecular recruitment, or therapeutic activity. Their modularity, genetic encodability, and intracellular functionality position them at the intersection of chemical biology, synthetic biology, functional genomics, and RNA medicine. This Review examines the mechanisms of RNA allostery, strategies for engineering ligand-responsive architectures, and applications in live-cell sensing, drug discovery, and therapeutic regulation. Representative systems are evaluated by target, structure, affinity, dynamic range, output modality, and application. We highlight aptazymes, conditional gene-control modules, biomarker-responsive circuits, and RNA-scaffolded proximity-inducing systems, and compare RNA devices with DNA aptamers, DNAzymes, and switches. Key translational barriers include context-dependent folding, intracellular instability, delivery, pharmacokinetics and pharmacodynamics, immunogenicity, and inadequate manufacturing and assay standardization. Advances in ensemble-resolved structural biology, high-throughput evolution, artificial intelligence-assisted design, and RNA delivery may establish allosteric aptamers as programmable pharmacological systems coupling molecular recognition to spatiotemporally controlled therapeutic activity.
No takes yet. Share an insight, caveat, or question.
Peng et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: